ALLOS THERAPEUTICS INC. (NASDAQ: ALTH)

View Portfolio
Back to Investopedia
Back to Investopedia




$6.91 0.04 (0.58%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
8.79
52-Week Low Price
5.34
Avg Volume (3 Mo.)
1.00 M
Market Cap
0.73 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.79
Shares
103.94 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -16% - ALTH has underperformed the S&P 500 by 42%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
IMPAX LABORATORIES INC (IPXL) $13.61 -  $0.03(0.22%)0.84 B
SAVIENT PHARMACEUTICALS (SVNT) $12.76 -  $0.31(2.49%)0.83 B
MERIDIAN BIOSCIENCES INC (VIVO) $20.42 -  $0.45(2.25%)0.81 B
PDL BIOPHARMA INC (PDLI) $6.62 -  $0.07(1.07%)0.78 B
VIROPHARMA INC (VPHM) $9.72 -  $0.32(3.46%)0.75 B
INTERMUNE INC (ITMN) $15.70 -  $0.20(1.29%)0.73 B
NEOGEN CORP (NEOG) $21.16 -  $0.12(0.57%)0.71 B
ALNYLAM PHARMACEUTICALS (ALNY) $16.96 -  $0.05(0.30%)0.70 B
MARTEK BIOSCIENCES CORP (MATK) $20.26 -  $0.26(1.30%)0.67 B
VIVUS INC (VVUS) $8.40 -  $0.16(1.94%)0.67 B
As of February 09, 2010 at 2:05 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
ALTH RELATED HEADLINES
arrow
Allos Therapeutics (ALTH) NewsBite - JP Morgan Starts ALTH at Overweight
Allos Therapeutics (NASDAQ: ALTH) opened at $6.98. So far today, the stock has hit a low of $6.86 and a high of $7.30. ALTH is now trading at $7.12, up $0.39 (5.79%). Over the last 52 weeks the stock has ranged from a low of $5.34 to a high of $9.30. ALTH shares are rising after analysts at JP Morgan initiated the stock at Overw...
At Market Intelligence Center 1/8/2010
arrow
Stock Watch: StockPreacher.com Issues Market Alert for Allos Therapeutics Inc.
Stock Watch: StockPreacher.com Issues Market Alert for Allos Therapeutics Inc.
by GlobeNewswire 12/8/2009
arrow
Allos Therapeutics (ALTH) NewsBite - ALTH Downgraded By Wells Fargo
Allos Therapeutics (ALTH) was downgraded today by analysts at Wells Fargo and the stock is now at $5.72, down $.90 (-13.6%) on volume of 5,155,649 shares traded. The analysts reduced ALTH to Market Perform from Outperform. Over the last 52 weeks the stock has ranged from a low of $4.68 to a high of $9.30. Allos Therapeutics stock has been showing support around $6...
At Market Intelligence Center 12/7/2009
arrow
Allos Therapeutics (ALTH) NewsBite - Stock Offering Pulls Down ALTH
Allos Therapeutics (NGM: ALTH) opened at $7.19. So far today, the stock has hit a low of $7.12 and a high of $7.39. ALTH is now trading at $7.18, down $0.14 (-1.85%). Over the last 52 weeks the stock has ranged from a low of $3.82 to a high of $9.30. ALTH shares are declining this morning after the company priced an offering of 14 million shares ...
At Market Intelligence Center 10/7/2009
arrow
Allos Therapeutics (NGM: ALTH) NewsBite - FDA Approves ALTH's Folotyn
Allos Therapeutics (NGM: ALTH) opened at $8.55. So far today, the stock has hit a low of $8.11 and a high of $8.66. ALTH is now trading at $8.32, up $0.17 (2.09%). Over the last 52 weeks the stock has ranged from a low of $3.82 to a high of $9.30. ALTH shares are on the move today after the FDA approved its injectable drug Folotyn as a treatment for pe...
At Market Intelligence Center 9/25/2009
arrow
With an experimental lymphoma drug on the line, options traders take a neutral to bullish stance on this pharmaceuticals firm
Allos Therapeutics Inc. (ALTH: sentiment, chart, options) has attracted considerable attention in recent weeks, as the company's experimental lymphoma drug, Folotyn, goes before the Food and Drug Administration (FDA)...(Read More)
By SchaeffersResearch 9/23/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1